Overview of management system for conflict of interest of the European Pharmacopoeia Commission and the United States Pharmacopoeia Convention

VernacularTitle:欧美药典委员会利益冲突管理制度概况
Author: XU Xinyi ; LIU Jian ; ZHANG Lin ; SHEN Xueyao ; ZHAO Jianfeng ; ZHANG Jun ; FU Jian ; SHU Rong
Publication Type:Journal Article
Keywords: pharmacopoeia; experts, conflict of interest; management; system, overview
From: Drug Standards of China 2024;25(1):0103-0108
CountryChina
Language:Chinese
Abstract: This article introduces an overview of management system for conflict of interest of the European Pharmacopoeia Commission (EPC) and the United States Pharmacopoeia Convention (USP). The EPC and USP have standardized the management system for conflict of interest in drug standard work in multiple management documents, such as the Guide for the Work, Code of Practice for the Work, Form for Declaration of Interests and Confidentiality Undertaking of the EPC, bylaws, Rules and Procedures of the Council of Experts, Code of Ethics, Standards of Conduct of the USP, in order to ensure the transparency and fairness of drug standard development, improve the credibility and rigor of drug standards. This article introduces the management system for conflict of interest of the EPC and USP, providing reference for the improvement of relevant management systems of the Chinese Pharmacopoeia Commission.
Full text:202408101327331411720240218.pdf